Tuohua Biological Technology Co. Ltd   Report issue

For profit Phase 2
Founded: Siping City China (2010)

Organization Overview

First Clinical Trial
2020
NCT04269525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Tuohua Biological Technology Co. Ltd

Active Ingredients

Drugs in Phase 2 Trials (1)

umbilical cord mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 2)

Pneumonia, Ventilator-Associated (Phase 2)

Pneumonia, Viral (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1